Trial Profile
A Phase 1, Open Label, Single Dose, Randomized, Cross Over Study To Estimate The Absolute Oral Bioavailability Of CP-690,550 In Healthy Subjects.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 13 Aug 2010
Price :
$35
*
At a glance
- Drugs Tofacitinib (Primary) ; Tofacitinib
- Indications Ankylosing spondylitis; Crohn's disease; Plaque psoriasis; Psoriatic arthritis; Renal transplant rejection; Rheumatoid arthritis; Ulcerative colitis
- Focus Pharmacokinetics
- 09 Aug 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 02 Aug 2010 Status changed from not yet recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 15 Jul 2010 Additional trial location [Singapur] identified as reported by ClinicalTrials.gov.